H-1B sponsorship profile: Novo Nordisk Research Center Seattle Inc. Across U.S. Department of Labor LCA disclosures, Novo Nordisk Research Center Seattle Inc filed 15 Labor Condition Applications covering 15 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 100% (15 certified of 15 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Novo Nordisk Research Center Seattle Inc’s H-1B petitions range from $75,046 at the low end to $275,000 at the high end, with a petition-weighted average of $154,340. That range reflects the mix of occupations the company sponsors, led by Senior Engineer I (3 petitions at $166,333 avg), followed by Data Scientist II and Associate Director-Business Development. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Novo Nordisk Research Center Seattle Inc is headquartered in Plainsboro, NJ under NAICS code 325412, and places H-1B workers across 3 states, most heavily in MA, CA, WA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Novo Nordisk Research Center Seattle Inc ranks. By H-1B petition volume, Novo Nordisk Research Center Seattle Inc is #12,524 of 119,880 employers nationally and #1,132 of 5,818 employers headquartered in NJ. Both ranks are computed live from the same underlying petition counts, not a separate estimate.